Regulation of cytokines by small RNAs during skin inflammation

被引:43
作者
Bak, Rasmus O. [1 ]
Mikkelsen, Jacob G. [1 ]
机构
[1] Univ Aarhus, Dept Human Genet, DK-8000 Aarhus C, Denmark
基金
英国医学研究理事会;
关键词
TUMOR-NECROSIS-FACTOR; AU-RICH ELEMENTS; ACTIVATED PROTEIN-KINASES; SMALL INTERFERING RNAS; MESSENGER-RNA; TNF-ALPHA; T-CELLS; MAP KINASE; TRANSCRIPTION FACTOR; TARGET RECOGNITION;
D O I
10.1186/1423-0127-17-53
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Intercellular signaling by cytokines is a vital feature of the innate immune system. In skin, an inflammatory response is mediated by cytokines and an entwined network of cellular communication between T-cells and epidermal keratinocytes. Dysregulated cytokine production, orchestrated by activated T-cells homing to the skin, is believed to be the main cause of psoriasis, a common inflammatory skin disorder. Cytokines are heavily regulated at the transcriptional level, but emerging evidence suggests that regulatory mechanisms that operate after transcription play a key role in balancing the production of cytokines. Herein, we review the nature of cytokine signaling in psoriasis with particular emphasis on regulation by mRNA destabilizing elements and the potential targeting of cytokine-encoding mRNAs by miRNAs. The proposed linkage between mRNA decay mediated by AU-rich elements and miRNA association is described and discussed as a possible general feature of cytokine regulation in skin. Moreover, we describe the latest attempts to therapeutically target cytokines at the RNA level in psoriasis by exploiting the cellular RNA interference machinery. The applicability of cytokine-encoding mRNAs as future clinical drug targets is evaluated, and advances and obstacles related to topical administration of RNA-based drugs targeting the cytokine circuit in psoriasis are described.
引用
收藏
页数:19
相关论文
共 163 条
[1]
RNAi therapeutics: Principles, prospects and challenges [J].
Aagaard, Lars ;
Rossi, John J. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (2-3) :75-86
[2]
Lentiviral-mediated RNA interference [J].
Abbas-Terki, T ;
Blanco-Bose, W ;
Déglon, N ;
Pralong, W ;
Aebischer, P .
HUMAN GENE THERAPY, 2002, 13 (18) :2197-2201
[3]
The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling [J].
Ananieva, Olga ;
Darragh, Joanne ;
Johansen, Claus ;
Carr, Julia M. ;
McIlrath, Joanne ;
Park, Jin Mo ;
Wingate, Andrew ;
Monk, Claire E. ;
Toth, Rachel ;
Santos, Susana G. ;
Iversen, Lars ;
Arthur, J. Simon C. .
NATURE IMMUNOLOGY, 2008, 9 (09) :1028-1036
[4]
Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) [J].
Anderson, David R. ;
Meyers, Marvin J. ;
Vernier, William F. ;
Mahoney, Matthew W. ;
Kurumbail, Ravi G. ;
Caspers, Nicole ;
Poda, Gennadiy I. ;
Schindler, John F. ;
Reitz, David B. ;
Mourey, Robert J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (11) :2647-2654
[6]
MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components [J].
Asirvatham, Ananthi J. ;
Gregorie, Christopher J. ;
Hu, Zihua ;
Magner, William J. ;
Tomasi, Thomas B. .
MOLECULAR IMMUNOLOGY, 2008, 45 (07) :1995-2006
[7]
Sustainable systemic delivery via a single injection of lentivirus into human skin tissue [J].
Baek, SC ;
Lin, Q ;
Robbins, PB ;
Fan, HR ;
Khavari, PA .
HUMAN GENE THERAPY, 2001, 12 (12) :1551-1558
[8]
The selectivity of protein kinase inhibitors: a further update [J].
Bain, Jenny ;
Plater, Lorna ;
Elliott, Matt ;
Shpiro, Natalia ;
Hastie, C. James ;
Mclauchlan, Hilary ;
Klevernic, Iva ;
Arthur, J. Simon C. ;
Alessi, Dario R. ;
Cohen, Philip .
BIOCHEMICAL JOURNAL, 2007, 408 :297-315
[9]
BAK, 2010, J BIOMEDICAL SCI, V17, P53
[10]
ARED 2.0: an update of AU-rich element mRNA database [J].
Bakheet, T ;
Williams, BRG ;
Khabar, KSA .
NUCLEIC ACIDS RESEARCH, 2003, 31 (01) :421-423